Selective growth hormone secretagogue receptor agonist with a well-characterised profile.
Modified GRF (1-29) analogue used in growth-hormone-releasing pathway research.
Stabilised GHRH analogue studied in adipose tissue and endocrine research.
Synthetic GHRH (1-29) fragment and a reference compound in somatotropic axis studies.